SVB Securities analyst Puneet Souda maintained a Buy rating on 908 Devices (MASS – Research Report) today and set a price target of $25.00. The company’s shares closed yesterday at $12.48.
According to TipRanks, Souda is an analyst with an average return of -9.4% and a 41.40% success rate. Souda covers the Healthcare sector, focusing on stocks such as Illumina, Olink Holding, and Agilent.
908 Devices has an analyst consensus of Moderate Buy, with a price target consensus of $25.00.
See the top stocks recommended by analysts >>
Based on 908 Devices’ latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $11.11 million and a GAAP net loss of $8.1 million. In comparison, last year the company earned a revenue of $8.28 million and had a GAAP net loss of $7.42 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics and adjacent markets.
